Let us help you customize your experience.
Tell us a little about yourself so we can share more relevant content and resources.
HealthTech Arkansas is an accelerator and early-stage investment fund that recruits worldwide for the most accomplished startups in the areas of digital health, medical devices, and diagnostic platforms. As one of the premier and most sought-after accelerator programs by early stage healthcare companies, the value proposition is unmatched: companies accepted into the program are guaranteed at least two pilot projects or clinical trials from among eleven leading hospitals, health systems, and physician practices in Arkansas. HealthTech Arkansas is the only program in the U.S. to guarantee pilot projects and clinical trials with healthcare providers.
The program offers:
In 2019, Arkansas Children’s, Inc. (“ACI”) joined the HTA provider coalition, which now includes the nine largest hospitals and health systems in the state along with two large independent physician practices. Through HTA, ACI contributes in two meaningful ways:
We are proud to announce our 2020 partners - Astarte and Zeto.
Astarte Medical is a precision nutrition company using software and predictive analytics to improve outcomes during the first 1,000 days of life. With an initial focus on preterm infants, Astarte Medical supports feeding protocols, practice, and decision-making in the neonatal ICU with a suite of digital tools and diagnostics designed to standardize feeding, optimize nutrition and quantify gut health.
Zeto has taken a significant step towards simplifying EEG. The Zeto product is the first and only dry electrode EEG headset and cloud platform cleared by the FDA for clinical use.
The cohort will participate in a program that provides them the opportunity to pilot solutions specifically identified by Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, OrthoArkansas, St. Bernards Healthcare, University of Arkansas for Medical Sciences (UAMS), and Washington Regional Medical Center as areas of opportunity within their organizations, from neonatal health and cardiac care to medical devices and software platforms. Each company will receive seed investment as well as complete and total access to clinicians and administrators while executing their pilot projects.